)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Clinical Laserthermia Systems
Clinical Laserthermia Systems (CLS) investor relations material
Clinical Laserthermia Systems Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary12 May, 2026
Executive summary
Revenue for Q1 2026 was SEK 1.3 million, down 72% year-over-year due to temporary alignment discussions with the neurosurgery partner.
Operating loss for Q1 2026 was SEK 9.6 million, reflecting lower revenue but stable operating expenses.
Strategic agreement post-quarter secured SEK 23 million in purchase orders for the Prism neurosurgery business, supporting future growth.
Clinical and commercial momentum continued in the U.S. with ClearPoint PrismⓇ System installations and increased LITT procedures.
The company is transitioning from alignment to accelerated growth, with a long-term partnership framework through 2030.
Financial highlights
Net sales for Q1 2026: SEK 1,276 thousand, down from SEK 4,496 thousand in Q1 2025.
Operating loss for Q1 2026: SEK 9,571 thousand, compared to SEK 7,868 thousand in Q1 2025.
Net loss for Q1 2026: SEK 7,365 thousand, improved from SEK 15,225 thousand in Q1 2025.
Earnings per share for Q1 2026: SEK -0.2, compared to SEK -0.7 in Q1 2025.
Cash and cash equivalents at March 31, 2026: SEK 13,035 thousand.
Outlook and guidance
Full-year 2026 revenue expected to show strong double-digit growth over 2025, weighted to the second half.
Revenue visibility improved with SEK 23 million in purchase orders secured for the Prism business.
Additional revenue anticipated from increased LITT procedures and commercial activity.
Positive cash flow guidance updated to Q1 2028, reflecting increased near-term investments.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Clinical Laserthermia Systems
- Gross margin exceeded targets and Prism neurosurgery sales grew, despite lower total net sales.CLS
Q4 202520 Feb 2026 - FDA clearance and financing boost growth prospects as neurosurgery focus drives improved results.CLSQ3 202514 Nov 2025
- Record Q2 sales and improved margins drive narrowed losses and strong growth outlook.CLSQ2 202522 Aug 2025
- CLS accelerates neurosurgery growth, narrows losses, and targets profitability by 2026.CLSQ3 202413 Jun 2025
- Revenue quadrupled and losses narrowed as neurosurgery focus and US expansion accelerated.CLSQ2 202413 Jun 2025
- Revenue up 43% and operating loss halved as CLS accelerates neurosurgery commercialization.CLSQ1 20256 Jun 2025
- CLS doubled sales, improved margins, and refocused on neurosurgery for high-margin growth.CLSQ4 20245 Jun 2025
Next Clinical Laserthermia Systems earnings date
Q2 202614 Aug, 2026
Clinical Laserthermia Systems
Next Clinical Laserthermia Systems earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage